2-trifluoromethylnicotinamide derivatives as HDL-cholesterol raising agents
US7897621B2 · kind B2 · utility
3Cited by
1References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 16, 2009 |
| Grant date | Mar 1, 2011 |
| Priority date | — |
| Expiry date | Mar 16, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds formula I:and pharmaceutically acceptable salts thereof, wherein R1 to R8 are as defined in the description and claims for use as HDL-cholesterol raising agents in the treatment and/or prophylaxis of diseases or disorders that can be treated with such agents such as dyslipidemia.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.